Composition of the data monitoring committee, its role, and reporting structure {21a}
ADVERSE EVENTS
n/a, explanation: Since this is a trial with a waiting list control condition (and not a placebo intervention control condition), blinding of participants and personnel is not possible. Therefore, the establishment of a data monitoring committee, which is normally installed in masked trials to supervise adverse events and potential relations to the experimental treatment conditions, is not necessary.